Adelene Q. Perkins

2010

In 2010, Adelene Q. Perkins earned a total compensation of $2M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 170% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$247,000
Option Awards$1,278,841
Salary$485,000
Other$7,782
Total$2,018,623

Perkins received $1.3M in option awards, accounting for 63% of the total pay in 2010.

Perkins also received $247K in non-equity incentive plan, $485K in salary and $7.8K in other compensation.

Rankings

In 2010, Adelene Q. Perkins' compensation ranked 3,033rd out of 10,439 executives tracked by ExecPay. In other words, Perkins earned more than 70.9% of executives.

ClassificationRankingPercentile
All
3,033
out of 10,439
71st
Division
Manufacturing
1,059
out of 3,838
72nd
Major group
Chemicals And Allied Products
205
out of 921
78th
Industry group
Drugs
107
out of 680
84th
Industry
Pharmaceutical Preparations
85
out of 481
82nd
Source: SEC filing on April 4, 2012.

Perkins' colleagues

We found four more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2010.

2010

Steven Holtzman

Infinity Pharmaceuticals

Executive Chair

2010

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2010

Julian Adams

Infinity Pharmaceuticals

President of R&D

2010

Pedro Santabarbara

Infinity Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like